Table 1 Characteristics of the studies selected for the meta-analysis
From: The prevalence of depression symptoms among infertile women: a systematic review and meta-analysis
ID | Authors | Year publication | countries | Income levels | Sample size | Type of infertility | Prevalence of depression | Age (Y) (mean ± SD) | Mean years of infertility (mean ± SD) | Type of Tools | Quality assessment |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Ramezanzadeh et al. [20] | 2004 | Iran | Low and middle | 370 | Primary and secondary | 40.80% | 28 ± 5.37 | 6.36 ± 4.18 | BDI | 3/5 |
2 | Alosaimi et al. [31] | 2015 | Saudi Arabia | High | 206 | Primary and secondary | 26.20% | NA | 5.4 ± 4.3 | MINI | 3/5 |
3 | Maroufizadeh et al. [2] | 2018 | Iran | Low and middle | 649 | Primary and secondary | 33.90% | 31/37 ± 5.69 | 5.62 ± 4.03 | HADS | 4/5 |
4 | Joelsson et al. [32] | 2017 | Sweden | High | 468 | Primary and secondary | 15.70% | 30.1 ± 4.8 | 1.8 ± 002 | HADS | 5/5 |
5 | Lakatos et al. [33] | 2017 | Hungary | High | 134 | Primary and secondary | 44.80% | 33.30 ± 4.85 | 3.61 ± 3.08 | BDI | 3/5 |
6 | Yusuf [34] | 2006 | Pakistan | Low and middle | 100 | Primary and secondary | 79% | 24.60 ± 5.40 | NA | DASS | 3/5 |
7 | Biringer et al. [35] | 2015 | Norway | High | 615 | Primary and secondary | 8.20% | 35.15 ± 6.28 | NA | HADS | 5/5 |
8 | Upkong and Orgi [36] | 2006 | Nigeria | Low and middle | 112 | Primary and secondary | 42.90% | 34.5 ± 5.5 | 4.46 ± 3.73 | BDI | 4/5 |
9 | Rostad et al. [37] | 2014 | Norway | High | 1413 | Primary and secondary | 6.40% | NA | NA | HADS | 3/5 |
10 | Verma et al. [38] | 2015 | India | Low and middle | 140 | Primary and secondary | 56.40% | 28.70 ± 5.94 | NA | HADS | 3/5 |
11 | Kalkhoran et al. [39] | 2011 | Iran | Low and middle | 30 | Primary and secondary | 46.70% | 29.2 0 ± 4.2 | 4.8 ± 0.5 | BDI | 3/5 |
12 | Peyvandi et al. [40] | 2009 | Iran | Low and middle | 200 | Primary and secondary | 62.00% | 33.39 ± 0.2 | 4.1 ± 0.6 | BDI | 4/5 |
13 | Sulyman et al. [41] | 2019 | Nigeria | 207 | Primary and secondary | 25.60% | 29.60 ± 4.0 | 5.60 ± 2.1 | HADS | 4/5 | |
14 | Vo et al. [42] | 2019 | Vietnam | Low and middle | 401 | Primary and secondary | 12.20% | 30.41 ± 4.47 | 3.10 ± 2.20 | PHQ-9 | 4/5 |
15 | Oladeji and OlaOlorun [43] | 2018 | Nigeria | Low and middle | 110 | Primary and secondary | 52.70% | 34.50 ± 5.70 | NA | PHQ-9 | 3/5 |
16 | Crawford et al. [25] | 2017 | USA | High | 416 | Primary and secondary | 41.00% | 34.25 ± 4.20 | 2.50 ± 0.60 | NIH-PROMIS | 4/5 |
17 | Al-Asadi and Hussein [44] | 2015 | Iraq | Low and middle | 251 | Primary and secondary | 68.90% | 24.26 ± 8.5 | NA | ICD-10 | 4/5 |
18 | Alhassan et al. [45] | 2014 | Ghana | Low and middle | 100 | Primary and secondary | 62.00% | 30.50 ± 6.30 | NA | BDI | 3/5 |
19 | Haririan eta l [27] | 2009 | Iran | Low and middle | 100 | Primary and secondary | 85.00% | 27.50 ± 4.40 | 7.01 ± 4.45 | BDI | 3/5 |
20 | Chiaffarino et al. [46] | 2011 | Italy | High | 872 | Primary and secondary | 17.90% | 35.25 ± 6.70 | NA | ZDS | 4/5 |
21 | Drosdzol and Skrzypulec [47] | 2009 | Poland | High | 206 | Primary and secondary | 35.44% | 29.80 ± 4.10 | NA | BDI | 4/5 |
22 | Ma et al. [48] | 2018 | China | Low and middle | 98 | Primary and secondary | 47.00% | 31.80 ± 4.80 | NA | ZDS | 3/5 |
23 | Wu et al. [49] | 2014 | China | Low and middle | 288 | Primary and secondary | 22.60% | 33.30 ± 3.80 | NA | CES-D10 | 3/5 |
24 | Naab et al. [24] | 2013 | Ghana | Low and middle | 203 | Primary and secondary | 11.00% | 31.25 ± 4.62 | 3.40 ± 2.70 | CES-D10 | 4/5 |
25 | Kissi et al. [22] | 2013 | Tunisia | Low and middle | 100 | Primary and secondary | 33.00% | 32.69 ± 4.91 | 5.19 ± 4.62 | HADS | 3/5 |
326 | Pinar et al. [26] | 2012 | Turkey | Low and middle | 160 | Primary and secondary | 65.00% | 25.23 ± 3.25 | 5.23 ± 3.42 | BDI | 3/5 |
27 | Psaros et al. [50] | 2012 | USA | High | 104 | Primary and secondary | 63.00% | 35.87 ± 0.4 | NA | BDI | 3/5 |
28 | Li et al. [51] | 2016 | China | Low and middle | 211 | Primary and secondary | 50.71% | NA | 2.80 ± 1.20 | ZDS | 4/5 |
29 | Khademi et al. [52] | 2004 | Iran | Low and middle | 681 | Primary and secondary | 40.10% | 27.78 ± 5.32 | 6.28 ± 3.83 | BDI | 4/5 |
30 | Jin et al. [53] | 2019 | China | Low and middle | 460 | Primary and secondary | 14.80% | 29.12 ± 4.36 | 5.60 ± 3.20 | ZDS | 3/5 |
31 | Khademi et al. [54] | 2005 | Iran | Low and middle | 251 | Primary and secondary | 39.00% | 29.60 ± 5.7 | 7.40 ± 4.6 | BDI | 4/5 |
32 | Musa et al. [55] | 2014 | Malaysia | Low and middle | 123 | Primary and secondary | 31.70% | NA | NA | DASS | 4/5 |